Position in XERS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,606,609
+$2,003,362 QoQ
Shares Held
455,380
+64.7% QoQ
Ownership
0.250%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#45
of 238 holders
Holding Since
Dec 2021
8 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Man Group plc holds $452,779,482 across 30 Drug Manufacturers - Specialty & Generic names. XERS ranks #15 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,805,003 | $129,707,515 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
601,019 | $101,295,742 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
134,890 | $73,087,447 | |
| 4 | VTRS |
Viatris Inc
|
3,523,052 | $55,946,065 | |
| 5 | PRGO |
PERRIGO Co plc
|
1,530,206 | $15,898,840 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
732,867 | $7,328,670 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
156,422 | $7,275,186 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
1,451,781 | $7,157,279 |
All Filings in XERS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,606,609 | 455,380 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,603,247 | 276,422 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $375,033 | 47,775 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $611,064 | 130,849 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $962,106 | 175,247 | Shares | Defined | 2025-05-15 | |
| 2024-03-31 | $439,840 | 199,023 | Shares | Defined | 2024-05-15 | |
| 2022-03-31 | $1,125,841 | 439,782 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,859,228 | 1,658,440 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||